Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intermittent ST Depression and Prognosis After Myocardial Infarction

This study has been completed.
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:
New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT00005217
First received: May 25, 2000
Last updated: January 27, 2016
Last verified: January 2016
  Purpose
To determine if intermittent ST depression (STD) had an independent impact on survival among myocardial infarction patients who participated in the Beta-Blocker Heart Attack Trial (BHAT).

Condition
Cardiovascular Diseases
Myocardial Infarction
Heart Diseases

Study Type: Observational

Resource links provided by NLM:


Further study details as provided by New York University School of Medicine:

Study Start Date: April 1988
Estimated Study Completion Date: March 1991
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   up to 100 Years   (Child, Adult, Senior)
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria
No eligibility criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00005217     History of Changes
Other Study ID Numbers: 1096  R01HL039641 
Study First Received: May 25, 2000
Last Updated: January 27, 2016
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Infarction
Cardiovascular Diseases
Heart Diseases
Myocardial Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Vascular Diseases

ClinicalTrials.gov processed this record on December 09, 2016